title: Cas and NEDD9 Contribute to Tumor Progression through Dynamic Regulation of the Cytoskeleton.
abstract: The Cas family proteins, p130(Cas) (Cas) and NEDD9, are adaptor molecules that regulate cytoskeletal dynamics to promote multiple cellular processes, including migration, invasion, proliferation, and survival. Because these functions are also critical for tumor initiation, growth, and metastasis, Cas and NEDD9 are well positioned to contribute to these oncogenic processes. Indeed, mouse models of cancer show that these proteins function during multiple stages of disease progression. Furthermore, in many human cancers, high expression of Cas and NEDD9 is associated with advanced stage disease and is predictive of poor outcome. This review explores the contribution of Cas and NEDD9 during cellular transformation and neoplastic growth, tumor progression, metastasis, and the development of therapeutic resistance. Given these roles, Cas and NEDD9 may prove to be viable candidates for use as biomarkers and therapeutic targets.
authors.affiliation: University of Virginia School of Medicine, Charlottesville, VA, USA.
authors.forename: Michael S
authors.initials: MS
authors.lastname: Guerrero
authors.forename: J Thomas
authors.initials: JT
authors.lastname: Parsons
authors.forename: Amy H
authors.initials: AH
authors.lastname: Bouton